Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT

OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). METHODS: Participants (aged 36–85 years) who completed the core study (RESILIENT [Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A.L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032371/
https://ncbi.nlm.nih.gov/pubmed/33597289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars